Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Share News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 101.80
Bid: 101.80
Ask: 102.00
Change: 0.80 (0.79%)
Spread: 0.20 (0.196%)
Open: 101.60
High: 102.00
Low: 101.40
Prev. Close: 101.00
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Off-key Hipgnosis Songs Fund accepts takeover from Concord

Thu, 18th Apr 2024 08:43

(Alliance News) - Hipgnosis Songs Fund Ltd on Thursday said it has agreed to a USD1.40 billion cash takeover from music rights acquirer Alchemy Copyrights, which trades as Concord Chorus Ltd.

Concord will pay USD1.16, or 93.2 pence, in cash per Hipgnosis Songs Fund share. The price is a 32% premium to its Wednesday close.

Shares in Hipgnosis Songs Fund jumped 31% to 92.60p in London on Thursday morning.

Hipgnosis Songs Fund, is a London-based music investment company, which has bought up the royalty rights to song catalogues of artists including the Red Hot Chili Peppers, Journey and Neil Young.

Los Angeles-based Alchemy trades as Concord, and has been acquiring music rights and companies for over ten years. Since 2015, it has deployed over USD2.8 billion of capital and completed over 100 transactions in recorded music, music publishing and theatricals.

In September 2023, it bought former London listing Round Hill Music Royalty Fund Ltd for USD468.8 million.

Concord said Higpnosis Songs Fund shareholders will stand to receive up to an extra USD25 million in total, if the investment adviser deal with Hipgnosis Song Management is ended.

Hipgnosis Songs Fund is in dispute with its investment adviser, alleging misconduct against Hipgnosis Songs Management Ltd and its founder Merck Mercuriadis.

The dispute was sparked by an arrangement, later rejected by Hipgnosis Songs Fund shareholders, to sell part of the fund's portfolio to a joint-venture between Hipgnosis Songs Management and private equity firm Blackstone Inc. This triggered board changes at the fund.

In March, Hipgnosis said it would divert its free cashflow toward paying down debt and wouldn't resume paying dividends "for the foreseeable future", after an independent study found a lower valuation for the company's portfolio.

On Thursday, Hipgnosis said it believes that the share price is unlikely to increase to match the offer price in the medium term as a result of "numerous company-specific and certain market issues".

"The board considers that, in order to achieve a material improvement in the share price, the company needs to undergo, and evidence the benefits of, substantial financial and governance changes to improve its financial performance," it stated.

Hipgnosis revealed it had spoken to a number of potentially interested parties during the course of its strategic review and received a number of indicative and preliminary proposals, including earlier approaches by Concord.

It pointed out that all alternative proposals were less certain, and at a lower value than USD1.16 secured in the offer from Concord.

Hipgnosis Songs Fund Chair Robert Naylor said: "The acquisition represents an attractive opportunity for our shareholders to immediately realise their holding at a premium, mitigating the risks we see ahead to achieving a material improvement in the share price."

"At the same time, the board is confident that Concord, one of the world's leading independent music companies, is the right owner to take on the Hipgnosis catalogue and manage it in the interests of composers and performers."

Naylor added the firm will now "encourage" Hipgnosis Song Management, as well as Blackstone, HSM's majority owner, "to agree an orderly termination of the investment advisory agreement".

"This would enable the payment of a larger consideration under the agreed transaction with Concord and bring to an end a period of uncertainty for all Hipgnosis stakeholders," Naylor stated.

Shareholders representing around 29% of Hipgnosis share capital have agreed to support the deal, including Directors and Investec Wealth & Investment Ltd.

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
16 Jun 2021 08:39

Hipgnosis taps investors for GBP150 million to add to music catalogue

Hipgnosis taps investors for GBP150 million to add to music catalogue

Read more
16 Jun 2021 08:37

LONDON MARKET OPEN: FTSE 100 shakes off mining drag as US Fed looms

LONDON MARKET OPEN: FTSE 100 shakes off mining drag as US Fed looms

Read more
16 Jun 2021 07:49

LONDON MARKET PRE-OPEN: Made.com to be worth GBP775 million on debut

LONDON MARKET PRE-OPEN: Made.com to be worth GBP775 million on debut

Read more
16 Jun 2021 07:20

Hipgnosis in £150m placing to fund new catalogue purchases

(Sharecast News) - Music rights buyer Hipgnosis said it planned to raise £150m in a share placing to fund what it called a "substantial" pipeline of songs.

Read more
14 Jun 2021 15:13

EXECUTIVE CHANGES: Gresham House Strategic chair departs immediately

EXECUTIVE CHANGES: Gresham House Strategic chair departs immediately

Read more
7 Jun 2021 13:42

Hipgnosis hails music streaming, TikTok boom as net asset value rises

Hipgnosis hails music streaming, TikTok boom as net asset value rises

Read more
4 Jun 2021 09:06

Hipgnosis Songs Fund buys music catalogue of hit producer Joel Little

Hipgnosis Songs Fund buys music catalogue of hit producer Joel Little

Read more
4 Jun 2021 07:53

Hipgnosis acquires songwriter Joel Little's catalogue

(Sharecast News) - Music intellectual property investor Hipgnosis Songs Fund has acquired the music catalogue of Grammy Award-winning songwriter, producer and musician Joel Little, it announced on Friday.

Read more
4 Jun 2021 07:50

LONDON MARKET PRE-OPEN: AstraZeneca appoints Aradhana Sarin as new CFO

LONDON MARKET PRE-OPEN: AstraZeneca appoints Aradhana Sarin as new CFO

Read more
21 May 2021 15:48

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
13 May 2021 11:36

Hipgnosis Songs Fund acquisition of music catalogue from Andy Wallace

Hipgnosis Songs Fund acquisition of music catalogue from Andy Wallace

Read more
13 May 2021 08:14

Hipgnosis buys catalogue from producer Andy Wallace

(Sharecast News) - Music rights fund Hipgnosis said it had bought a catalogue from Grammy Award-winning producer, mixer and engineer, Andy Wallace for an undisclosed sum.

Read more
5 May 2021 15:25

IN BRIEF: Hipgnosis Songs buys catalogue of producer Andrew Wotman

IN BRIEF: Hipgnosis Songs buys catalogue of producer Andrew Wotman

Read more
5 May 2021 08:21

Hipgnosis snaps up catalogue of Grammy winning producer Andrew Wotman

(Sharecast News) - Intellectual property investment firm Hipgnosis Songs Fund has acquired a music catalogue from Andrew Wotman, the recently awarded 2021 Grammy winner for Producer Of The Year.

Read more
30 Apr 2021 10:06

Hipgnosis Songs Fund raises cash for new investments

Hipgnosis Songs Fund raises cash for new investments

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.